We have come to know very well the drug Phenylpropanolamine as it is a popular medication that doctors give for decongested noses. But it has a history that most people do not know, a history that supposedly have been improved but never known publicly. SCIENTIFIC studies in 1988, 1999 and 2000 agreed that there is a risk for hemorrhagic stroke among women who used phenylpropanolamine (PPA). The 1999 study came from the Yale University (New Haven, Connecticut). And the one in 2000 was conducted by a team that WN Kernan led and published in the December 2000 issue of the North England Journal of Medicine, a publication of the Massachusetts Medical Society. The 1988 study was a psychiatric review of 37 cases published in North America and Europe since 1960. In this study that the Lake-Masson-Quirk team published in Pharmacopsychiatry (July 1988), it was noted that ingestion of phenylpropanolamine had resulted in diagnosed cases of acute mania, paranoid schizophrenia and
Groundbreaking science before the news